<?xml version="1.0" encoding="UTF-8"?>
<xml>
 <records>
  <record>
   <ref-type name="Journal Article">17</ref-type>
   <contributors>
    <authors>
     <author>D’yakonov, V.A.</author>
     <author>Dzhemileva, L.U.</author>
     <author>Tuktarova, R.A.</author>
     <author>Ishmukhametova, S.R.</author>
     <author>Yunusbaeva, M.M.</author>
     <author>Ramazanov, I.R.</author>
     <author>Dzhemilev, U.M.</author>
    </authors>
   </contributors>
   <titles>
    <title></title>
   </titles>
   <dates>
    <year>2017</year>
    <pub-dates>
     <date>2018-01-31</date>
    </pub-dates>
   </dates>
   <abstract>Novel steroid derivatives of 5Z,9Z-dienoic acids were prepared by the DCC/DMAP-catalyzed esterification of (5Z,9Z)-tetradeca-5,9-dienoic acid with hydroxy steroids. High cytotoxicity towards the HEK293, Jurkat, K562 cancer cell lines and human topoisomerase I (hTop1) inhibitory activity in vitro were found for the synthesized acids. A probable mechanism of topoisomerase I inhibition was hypothesized on the basis of in silico studies resorting to docking.</abstract>
   <urls>
    <web-urls>
     <url>https://repo.bashgmu.ru/publication/637</url>
    </web-urls>
    <pdf-urls>
     <url>https://repo.bashgmu.ru/files/705</url>
    </pdf-urls>
   </urls>
  </record>
 </records>
</xml>
